Procurement Summary
Country: USA
Summary: Ngs Malignancy Testing
Deadline: 14 Jul 2026
Posting Date: 11 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144937609
Document Ref. No.: 36C25026Q0709
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
SOURCES SOUGHT NOTICE
This Sources Sought Notice is to determine the presence of any businesses capable of satisfying a requirement at the Richard L. Roudebush VAMC for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens.
NOTE TO RESPONDERS: This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort.
BACKGROUND
The Hematology department at Richard L. Roudebush VA Medical Center s Pathology & Laboratory Medicine Service (PALMS) requires a one-year, firm fixed price contract for Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. NGS testing is an advanced test methodology at the gene level for detecting various forms of diseases through patient blood specimens. Testing shall provide detailed gene test results of at least 600 targeted genes and produce detailed treatment plans. This contract is needed for Hematology providers to obtain repeat NGS testing that may not be covered under the VA National Precision Oncology Program (NPOP) national contract, for patients with changes in their diagnosis.
North American Industry Classification System (NAICS) code: 621511
VENDOR CAPABILITY
Interes...
Notice ID: 36c25026q0709
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 250-network contract office 10 (36c250)
Product Service Code: q301 - reference laboratory testing
NAICS Code: 621511 - Medical Laboratories
Inactive Dates: sep 12, 2026
Inactive Policy: manual
Documents
Tender Notice
Documents.zip